Literature DB >> 21396218

Resistance patterns of multidrug-resistant tuberculosis in Western Province, Papua New Guinea.

G Simpson1, C Coulter, J Weston, T Knight, R Carter, S Vincent, L Robertus, A Konstantinos.   

Abstract

Few data are available on tuberculosis (TB) drug resistance patterns in Papua New Guinea (PNG) due to the lack of facilities for mycobacterial culture. Many patients from the Western Province seek care in Queensland health clinics in the Torres Strait. Since 2000, we have treated 161 TB cases from PNG, of whom 40 proved to have multidrug-resistant TB (MDR-TB; two human immunodeficiency virus positive). Drug susceptibility testing (DST) shows high levels of resistance to other drugs in the MDR-TB cases (streptomycin 93%, ethionamide 87%, ethambutol 18%, pyrazinamide 10%). No extensively drug-resistant TB (XDR-TB) has been identified. MDR-TB seems to be highly prevalent in the Western Province of PNG, and unless treatment is guided by DST, the risk of XDR-TB emerging is high.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396218     DOI: 10.5588/ijtld.10.0347

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  10 in total

1.  TB incidence and characteristics in the remote gulf province of Papua New Guinea: a prospective study.

Authors:  Gail B Cross; Katie Coles; Mandana Nikpour; Owen A Moore; Justin Denholm; Emma S McBryde; Damon P Eisen; Beverlyn Warigi; Robyn Carter; Sushil Pandey; Paul Harino; Peter Siba; Christopher Coulter; Ivo Mueller; Suparat Phuanukoonnon; Marc Pellegrini
Journal:  BMC Infect Dis       Date:  2014-02-20       Impact factor: 3.090

2.  Drug-resistant tuberculosis diagnosis since Xpert® MTB/RIF introduction in Papua New Guinea, 2012-2017.

Authors:  E K Lavu; K Johnson; J Banamu; S Pandey; R Carter; C Coulter; P Aia; S S Majumdar; B J Marais; S M Graham; J Vince
Journal:  Public Health Action       Date:  2019-09-21

Review 3.  'Z(S)-MDR-TB' versus 'Z(R)-MDR-TB': improving treatment of MDR-TB by identifying pyrazinamide susceptibility.

Authors:  Ying Zhang; Kwok Chiu Chang; Chi-Chiu Leung; Wing Wai Yew; Brigitte Gicquel; Dorothy Fallows; Gilla Kaplan; Richard E Chaisson; Wenhong Zhang
Journal:  Emerg Microbes Infect       Date:  2012-07-25       Impact factor: 7.163

4.  Diversity of Mycobacterium tuberculosis and drug resistance in different provinces of Papua New Guinea.

Authors:  Serej D Ley; Paul Harino; Kilagi Vanuga; Ruben Kamus; Robyn Carter; Christopher Coulter; Sushil Pandey; Julia Feldmann; Marie Ballif; Peter M Siba; Suparat Phuanukoonnon; Sebastien Gagneux; Hans-Peter Beck
Journal:  BMC Microbiol       Date:  2014-12-05       Impact factor: 3.605

5.  A prospective study of tuberculosis drug susceptibility in sabah, malaysia, and an algorithm for management of isoniazid resistance.

Authors:  Muhammad Redzwan S Rashid Ali; Uma Parameswaran; Timothy William; Elspeth Bird; Christopher S Wilkes; Wai Khew Lee; Tsin Wen Yeo; Nicholas M Anstey; Anna P Ralph
Journal:  J Trop Med       Date:  2015-03-09

6.  Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?

Authors:  Soazic Grard; Gaud Catho; Florent Valour; Anissa Bouaziz; Thomas Perpoint; Evelyne Braun; François Biron; Patrick Miailhes; Tristan Ferry; Christian Chidiac; Pierre-Jean Souquet; Sébastien Couraud; Gérard Lina; Sylvain Goutelle; Nicolas Veziris; Oana Dumitrescu; Florence Ader
Journal:  Open Forum Infect Dis       Date:  2015-12-22       Impact factor: 3.835

7.  The social determinants of tuberculosis treatment adherence in a remote region of Papua New Guinea.

Authors:  Tanya Diefenbach-Elstob; David Plummer; Robert Dowi; Sinba Wamagi; Bisato Gula; Keyanato Siwaeya; Daniel Pelowa; Peter Siba; Jeffrey Warner
Journal:  BMC Public Health       Date:  2017-01-13       Impact factor: 3.295

8.  Isolation of anti-mycobacterial compounds from Curtisia dentata (Burm.f.) C.A.Sm (Curtisiaceae).

Authors:  Victor O Fadipe; Nkoana I Mongalo; Andy R Opoku; Preachers M Dikhoba; Tshepiso J Makhafola
Journal:  BMC Complement Altern Med       Date:  2017-06-12       Impact factor: 3.659

Review 9.  A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.

Authors:  Michael G Whitfield; Heidi M Soeters; Robin M Warren; Talita York; Samantha L Sampson; Elizabeth M Streicher; Paul D van Helden; Annelies van Rie
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

10.  The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey.

Authors:  Paul Aia; Margaret Kal; Evelyn Lavu; Lucy N John; Karen Johnson; Chris Coulter; Julia Ershova; Olga Tosas; Matteo Zignol; Shalala Ahmadova; Tauhid Islam
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.